RT Book, Section
A1 Mangla, Ashvarya
A1 Gupta, Saurabh
A2 Crawford, Michael H.
SR Print(0)
ID 57950546
T1 Chapter 3. Antiplatelet Therapy
T2 CURRENT Diagnosis & Treatment Cardiology, 4e
YR 2014
FD 2014
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-180127-0
LK accessmedicine.mhmedical.com/content.aspx?aid=57950546
RD 2022/05/26
AB Atherosclerosis  is  a  leading  cause  of  cardiovascular  disease.  Atherosclerotic  plaques  can  acutely  rupture,  exposing  a  necrotic  core  that  sets  off  the  coagulation  cascade,  ultimately  culminating  in  vascular  occlusion.  Activation  of  platelets  is  the  initial  event  in  this  cascade  and,  depending  on  the  vascular  bed  involved,  can  cause  acute  coronary  syndromes,  ischemic  stroke,  mesenteric  ischemia,  or  acute  limb  ischemia.  Antiplatelet  therapy  forms  the  core  of  treatment  for  both  acute  and  chronic  atherosclerotic  disease.  In  this  chapter,  we  will  discuss  antiplatelet  therapy  in  the  treatment  of  cardiovascular  disease.